MetLife Small Company Equity Investor (MSVVX)

Fund Assets	7.71M
Expense Ratio	1.24%
Min. Investment	$5,000
Turnover	90.00%
Dividend (ttm)	n/a
Dividend Yield	n/a
Dividend Growth	n/a
Payout Frequency	Annual
Ex-Dividend Date	Dec 18, 2025

Previous Close	5.70
YTD Return	13.55%
1-Year Return	15.34%
5-Year Return	58.42%
52-Week Low	4.67
52-Week High	13.85
Beta (5Y)	n/a
Holdings	78
Inception Date	Dec 19, 2018

About MSVVX

MetLife Small Company Equity Fund Investor Shares is an actively managed mutual fund designed to provide long-term capital appreciation with lower volatility compared to the broader U.S. small company market. This fund primarily invests at least 80% of its net assets, plus borrowings, in equities of small-cap companies—typically businesses with smaller market capitalizations that are generally considered to have higher growth potential but also increased volatility relative to large-cap peers. The fund follows a "small blend" investment style, balancing exposure to both growth and value-oriented small-cap stocks across various sectors, including industrials, financial services, healthcare, and consumer cyclical industries. Its strategy aims to capture growth opportunities among smaller U.S. businesses while employing risk management processes intended to reduce overall portfolio fluctuations. The fund charges a net expense ratio of 1.23% for Investor Shares after waivers, and maintains a relatively high portfolio turnover rate, reflecting active trading as the managers adjust holdings. Overall, MetLife Small Company Equity Fund Investor Shares plays a role in diversifying portfolios with exposure to U.S. small-cap equities, offering investors potential for long-term growth with an emphasis on managing volatility.

• Fund Family: MetLife Investment Management
• Category: Small Blend
• Performance Rating: Average
• Risk Rating: Below Average
• Stock Exchange: NASDAQ
• Ticker Symbol: MSVVX
• Share Class: Investor Shares
• Index: Russell 2000 TR

Performance

MSVVX had a total return of 15.34% in the past year, including dividends. Since the fund's inception, the average annual return has been 12.26%.

Equivalent Funds

These are funds that follow the same index from the other major fund companies.

Symbol	Provider	Name	Expense Ratio
SWSSX	Schwab	Schwab Small Cap Index Fund	0.04%
FSCRX	Fidelity	Fidelity Small Cap Discovery Fund	0.66%
FSSLX	Fidelity	Fidelity Series Small Cap Core	0.01%
FLXSX	Fidelity	Fidelity Flex Small Cap Index Fund	n/a
SWSCX	Schwab	Schwab Small-Cap Equity Fund™	1.09%

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
MSVIX	Institutional Shares	0.99%

Top 10 Holdings

19.70% of assets

Name	Symbol	Weight
Cash & Cash Equivalents	n/a	3.66%
Halozyme Therapeutics, Inc.	HALO	1.99%
Kontoor Brands, Inc.	KTB	1.99%
State Street SPDR S&P Biotech ETF	XBI	1.87%
Advanced Energy Industries, Inc.	AEIS	1.85%
Praxis Precision Medicines, Inc.	PRAX	1.74%
iShares Russell 2000 ETF	IWM	1.72%
Zions Bancorporation, National Association	ZION	1.65%
Gates Industrial Corporation Ltd.	GTES	1.64%
StandardAero, Inc.	SARO	1.60%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 18, 2025	$8.5742	Dec 19, 2025
Dec 18, 2024	$0.9958	Dec 19, 2024
Dec 28, 2023	$0.0631	Dec 29, 2023
Dec 19, 2023	$0.4663	Dec 20, 2023
Dec 29, 2022	$0.0125	Dec 30, 2022
Dec 15, 2022	$0.3052	Dec 16, 2022

Data Sources: Tiingo, Twelve Data, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Aug 27, 2026

Data Sources Report a data error